• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAXTER HEALTHCARE - CARTAGO CLEARLINK LUER ACTIVATED VALVE; SET, ADMINISTRATION, INTRAVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAXTER HEALTHCARE - CARTAGO CLEARLINK LUER ACTIVATED VALVE; SET, ADMINISTRATION, INTRAVASCULAR Back to Search Results
Catalog Number 2H8401
Medical Device Problem Code Fluid/Blood Leak (1250)
Health Effect - Clinical Code No Consequences Or Impact To Patient (2199)
Date of Event 01/19/2018
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
(b)(6).The device has been received and the evaluation is in progress.Should additional relevant information become available, a supplemental report will be submitted.
 
Event or Problem Description
It was reported that a clearlink solution set was leaking.This event occurred during patient infusion of zoledronic acid while using an unspecified infusion pump.The location of the leak was not specified.There was no patient injury or medical intervention associated with this event.No additional information is available.
 
Additional Manufacturer Narrative
Two devices were received for evaluation: device #1: during visual inspection, a hole was observed in the tubing.Clear passage, pressure and functional testing were performed and the leak was confirmed due to a hole in the tubing.The reported condition was verified.The cause was determined to be a human error during the manufacturing process.Device #2: visual inspection did not identify any abnormalities that could have contributed to the reported condition.Clear passage, pressure and functional testing were all completed and performed according to product specifications.The reported condition was not verified.A batch review was conducted and there were no deviations found related to this reported condition during the manufacture of this lot.Should additional relevant information become available, a supplemental report will be submitted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CLEARLINK LUER ACTIVATED VALVE
Common Device Name
SET, ADMINISTRATION, INTRAVASCULAR
Manufacturer (Section D)
BAXTER HEALTHCARE - CARTAGO
cartago
MDR Report Key7276753
Report Number1416980-2018-00811
Device Sequence Number2273812
Product Code FPA
UDI-Device Identifier00085412049090
UDI-Public(01)00085412049090
Combination Product (Y/N)N
Initial Reporter StateCA
Initial Reporter CountryUS
PMA/510(K) Number
K112893
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Nurse
Type of Report Initial,Followup
Report Date (Section B) 03/20/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Other
Device Expiration Date09/12/2022
Device Catalogue Number2H8401
Device Lot NumberR17I12031
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer02/05/2018
Initial Date Received by Manufacturer 01/23/2018
Supplement Date Received by Manufacturer03/08/2018
Initial Report FDA Received Date02/16/2018
Supplement Report FDA Received Date03/20/2018
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
ZOLEDRONIC ACID
-
-